Diabetes acceleration or prevention by a coxsackievirus B4 infection: Critical requirements for both interleukin-4 and gamma interferon

Journal of Virology

Volumn 79, Issue 2, 2005, Pages 1045-1052

  Serreze, David V ^a   Wasserfall, Clive ^b   Ottendorfer, Eric W ^b   Stalvey, Michael ^c   Pierce, Melissa A ^a   Gauntt, Charles ^d   O'Donnell, Brian ^b   Flanagan, James B ^b   Campbell Thompson, Martha ^b   Ellis, Tamir M ^b   Atkinson, Mark A ^b  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS B4; COXSACKIEVIRUS B4 EDWARDS STRAIN; DIABETES MELLITUS; DIABETOGENESIS; FEMALE; GENE DISRUPTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS STRAIN;

ANIMALS; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; PANCREAS;

EID: 19944426633     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.2.1045-1052.2005     Document Type: Article

References (30)

1. Abiru, N., L. Yu, M. Redondo, and G. Eisenbarth. 2000. Modification of the environment is not the most efficient way to prevent type 1 diabetes. Diabetes Technol. Ther. 2:609-616.
2. Atkinson, M., and G. Eisenbarth. 2001. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229.
3. Bach, J. F. 1994. Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. Clin. Immunol. Immunopathol. 72:56-61.
4. Balasa, B., J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick. 1998. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes. J. Immunol. 161:4420-4427.
5. Caggana, M., N. P. Chan, and A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:4797-4803.
6. Chapman, N. M., A. I. Ramsingh, and S. Tracy. 1997. Genetics of coxsackievirus virulence. Curr. Top. Microbiol. Immunol. 223:227-258.
7. Crowell, R. L., and B. J. Landau. 1997. A short history and introductory background on the coxsackieviruses of group B. Curr. Top. Microbiol. Immunol. 223:1-11.
8. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727-738.
9. Falcone, M., and N. Sarvetnick. 1999. Cytokines that regulate autoimmune responses. Curr. Opin. Immunol. 11:670-676.
10. Fohlman, J., and G. Friman. 1993. Is juvenile diabetes a viral disease? Ann. Med. 25:569-574.
11. Gamble, D. R., M. L. Kinsley, M. G. Fitzgerald, R. Bolton, and K. W. Taylor. 1969. Viral antibodies in diabetes mellitus. Br. Med. J. 3:627-630.
12. Gerling, I. C., D. V. Serreze, S. W. Christianson, and E. H. Leiter. 1992. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41:1672-1676.
13. Horwitz, M. S., L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781-785.
14. Horwitz, M. S., A. Ilic, C. Fine, B. Balasa, and N. Sarvetnick. 2004. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin. Immunol. 110:134-144.
15. Huber, S. A., C. J. Gauntt, and P. Sakkinen. 1999. Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity. Adv. Virus Res. 51:35-72.
16. Hyoty, H., M. Hiltunen, and M. Lannrot. 1998. Enterovirus infections and insulin dependent diabetes mellitus-evidence for causality. Clin. Diagn. Virol. 9:77-34.
17. Jaeckel, E., M. Manns, and M. Von Herrath. 2002. Viruses and diabetes. Ann. N. Y. Acad. Sci. 958:7-25.
18. Maugh, T. H. 1975. Diabetes-epidemiology suggests a viral connection. Science 188:347-351.
19. Pierce, M. A., H. D. Chapman, C. M. Post, A. Svetlanov, S. Efrat, M. Horwitz, and D. V. Serreze. 2003. Adenovirus early region 3 (E3) anti-apoptotic 10.4K, 14.5K, and 14.7K genes decrease the incidence of autoimmune diabetes in NOD mice. Diabetes 52:1119-1127.
20. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab. Rev. 14:129-151.
21. Ramsingh, A. L., W. T. Lee, D. N. Collins, and L. E. Armstrong. 1997. Differential recruitment of B and T cells in coxsackievirus B4-induced pancreatitis is influenced by a capsid protein. J. Virol. 71:8690-8697.
22. Serreze, D., E. Ottendorfer, C. Gauntt, T. M. Ellis, and M. A. Atkinson. 2000. Acceleration of insulin dependent diabetes mellitus by a coxsackievirus infection requires a preexisting critical mass of autoreactive T cells in pancreatic islets. Diabetes 49:708-711.
23. Serreze, D. V., H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch. 2001. Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166:1352-1359.
24. Serreze, D. V., H. D. Chapman, D. S. Varnum, M. S. Hanson, P. C. Reifsnyder, S. D. Richard, S. A. Fleming, E. H. Leiter, and L. D. Shultz. 1996. B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu(null) mice. J. Exp. Med. 184:2049-2053.
25. Thomas, H. E., J. L. Parker, R. D. Schreiber, and T. W. H. Kay. 1998. IFNγ action on pancreatic β cells causes MHC class I upregulation but not diabetes. J. Clin. Investig. 102:1249-1257.
26. Tian, J., P. V. Lehmann, and D. L. Kaufman. 1994. T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1979-1984.
27. Tracy, S., K. M. Drescher, N. M. Chapman, K. S. Kim, S. D. Carson, S. Pirruccello, P. H. Lane, J. R. Romero, and J. S. Leser. 2002. Toward testing the hypothesis that group B coxsackieviruses (CBV) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76:12097-12111.
28. Wen, L., J. Peng, Z. Li, and F. S. Wong. 2004. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol. 172:3173-3180.
29. Yap, I. S., G. Giddings, E. Pocock, and J. K. Chantler. 2003. Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J. Gen. Virol. 84:3051-3068.
30. Yoon, J. W., M. Austin, T. Onodera, and A. L, Notkins. 1979. Virus-induced diabetes-mellitus-isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300:1173-1179.